A required role for CCN5 in inhibition of BC progression is similarly found in SP-MCF-7 model (Figs 4–6) to extend the antitumorigenic role in aggressive BC24, 25, 32, 44, 45. The gene discussed is CCN5; the disease is breast cancer.